NTP-LORAZEPAM TABLET

Pays: Canada

Langue: anglais

Source: Health Canada

Ingrédients actifs:

LORAZEPAM

Disponible depuis:

TEVA CANADA LIMITED

Code ATC:

N05BA06

DCI (Dénomination commune internationale):

LORAZEPAM

Dosage:

1.0MG

forme pharmaceutique:

TABLET

Composition:

LORAZEPAM 1.0MG

Mode d'administration:

ORAL

Unités en paquet:

100/1000

Type d'ordonnance:

Targeted (CDSA IV)

Domaine thérapeutique:

BENZODIAZEPINES

Descriptif du produit:

Active ingredient group (AIG) number: 0110731001; AHFS:

Statut de autorisation:

CANCELLED PRE MARKET

Date de l'autorisation:

2015-08-06

Résumé des caractéristiques du produit

PRESCRIBING INFORMATION
NTP-LORAZEPAM
(LORAZEPAM)
ORAL TABLETS
ANXIOLYTIC - SEDATIVE
Teva Canada Ltd.
30 Novopharm Court
Toronto, Ontario
M1B 2K9
Submission Control No.: 167480
Date of Preparation:
October 11, 2013
2
NTP-LORAZEPAM
(lorazepam)
Oral Tablets
TABLE OF CONTENTS
ACTION.........................................................................................................................................
3
INDICATIONS AND CLINICAL USE
......................................................................................
3
CONTRAINDICATIONS
............................................................................................................
3
WARNINGS
..................................................................................................................................
4
PRECAUTIONS
...........................................................................................................................
4
DRUG INTERACTIONS
.............................................................................................................
6
ADVERSE REACTIONS
.............................................................................................................
6
SYMPTOMS AND TREATMENT OF OVERDOSAGE
......................................................... 7
DOSAGE AND ADMINISTRATION
........................................................................................
8
AVAILABILITY OF DOSAGE FORMS
...................................................................................
9
PHARMACOLOGY
...................................................................................................................
10
TOXICOLOGY
..........................................................................................................................
13
REFERENCES
............................................................................................................................
16
3
ACTION
NTP-LORAZEPAM (lorazepam) is an active benzodiazepine with a
depressant action on the
central n